Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2026-06-09 @ 11:28 AM
Study NCT ID:
NCT01530334
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2012-01-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment
Sponsor:
AstraZeneca
Organization: